Reports
Sale
Global Bleeding Disorders Therapeutics Market Size, Report: By Disease Type: Hemophilia A, Hemophilia B, Von Willebrand Disease, Liver Disease, Others; By Drug Class: Plasma Derived Coagulation Factor Concentrates, Recombinant Coagulation Factor Concentrates, Others; Regional Analysis; Competitive Landscape; 2024-2032
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Opportunities and Challenges in the Market
8 Global Bleeding Disorders Therapeutics Market Analysis
8.1 Key Industry Highlights
8.2 Global Bleeding Disorders Therapeutics Historical Market (2017-2023)
8.3 Global Bleeding Disorders Therapeutics Market Forecast (2024-2032)
8.4 Global Bleeding Disorders Therapeutics Market by Disease Type
8.4.1 Hemophilia A
8.4.1.1 Historical Trend (2017-2023)
8.4.1.2 Forecast Trend (2024-2032)
8.4.2 Hemophilia B
8.4.2.1 Historical Trend (2017-2023)
8.4.2.2 Forecast Trend (2024-2032)
8.4.3 Von Willebrand Disease
8.4.3.1 Historical Trend (2017-2023)
8.4.3.2 Forecast Trend (2024-2032)
8.4.4 Liver Disease
8.4.4.1 Historical Trend (2017-2023)
8.4.4.2 Forecast Trend (2024-2032)
8.4.5 Others
8.5 Global Bleeding Disorders Therapeutics Market by Drug Class
8.5.1 Plasma Derived Coagulation Factor Concentrates
8.5.1.1 Historical Trend (2017-2023)
8.5.1.2 Forecast Trend (2024-2032)
8.5.2 Recombinant Coagulation Factor Concentrates
8.5.2.1 Historical Trend (2017-2023)
8.5.2.2 Forecast Trend (2024-2032)
8.5.3 Others
8.6 Global Bleeding Disorders Therapeutics Market by Region
8.6.1 North America
8.6.1.1 Historical Trend (2017-2023)
8.6.1.2 Forecast Trend (2024-2032)
8.6.2 Europe
8.6.2.1 Historical Trend (2017-2023)
8.6.2.2 Forecast Trend (2024-2032)
8.6.3 Asia Pacific
8.6.3.1 Historical Trend (2017-2023)
8.6.3.2 Forecast Trend (2024-2032)
8.6.4 Latin America
8.6.4.1 Historical Trend (2017-2023)
8.6.4.2 Forecast Trend (2024-2032)
8.6.5 Middle East and Africa
8.6.5.1 Historical Trend (2017-2023)
8.6.5.2 Forecast Trend (2024-2032)
9 North America Bleeding Disorders Therapeutics Market Analysis
9.1 United States of America
9.1.1 Historical Trend (2017-2023)
9.1.2 Forecast Trend (2024-2032)
9.2 Canada
9.2.1 Historical Trend (2017-2023)
9.2.2 Forecast Trend (2024-2032)
10 Europe Bleeding Disorders Therapeutics Market Analysis
10.1 United Kingdom
10.1.1 Historical Trend (2017-2023)
10.1.2 Forecast Trend (2024-2032)
10.2 Germany
10.2.1 Historical Trend (2017-2023)
10.2.2 Forecast Trend (2024-2032)
10.3 France
10.3.1 Historical Trend (2017-2023)
10.3.2 Forecast Trend (2024-2032)
10.4 Italy
10.4.1 Historical Trend (2017-2023)
10.4.2 Forecast Trend (2024-2032)
10.5 Others
11 Asia Pacific Bleeding Disorders Therapeutics Market Analysis
11.1 China
11.1.1 Historical Trend (2017-2023)
11.1.2 Forecast Trend (2024-2032)
11.2 Japan
11.2.1 Historical Trend (2017-2023)
11.2.2 Forecast Trend (2024-2032)
11.3 India
11.3.1 Historical Trend (2017-2023)
11.3.2 Forecast Trend (2024-2032)
11.4 ASEAN
11.4.1 Historical Trend (2017-2023)
11.4.2 Forecast Trend (2024-2032)
11.5 Australia
11.5.1 Historical Trend (2017-2023)
11.5.2 Forecast Trend (2024-2032)
11.6 Others
12 Latin America Bleeding Disorders Therapeutics Market Analysis
12.1 Brazil
12.1.1 Historical Trend (2017-2023)
12.1.2 Forecast Trend (2024-2032)
12.2 Argentina
12.2.1 Historical Trend (2017-2023)
12.2.2 Forecast Trend (2024-2032)
12.3 Mexico
12.3.1 Historical Trend (2017-2023)
12.3.2 Forecast Trend (2024-2032)
12.4 Others
13 Middle East and Africa Bleeding Disorders Therapeutics Market Analysis
13.1 Saudi Arabia
13.1.1 Historical Trend (2017-2023)
13.1.2 Forecast Trend (2024-2032)
13.2 United Arab Emirates
13.2.1 Historical Trend (2017-2023)
13.2.2 Forecast Trend (2024-2032)
13.3 Nigeria
13.3.1 Historical Trend (2017-2023)
13.3.2 Forecast Trend (2024-2032)
13.4 South Africa
13.4.1 Historical Trend (2017-2023)
13.4.2 Forecast Trend (2024-2032)
13.5 Others
14 Market Dynamics
14.1 SWOT Analysis
14.1.1 Strengths
14.1.2 Weaknesses
14.1.3 Opportunities
14.1.4 Threats
14.2 Porter’s Five Forces Analysis
14.2.1 Supplier’s Power
14.2.2 Buyer’s Power
14.2.3 Threat of New Entrants
14.2.4 Degree of Rivalry
14.2.5 Threat of Substitutes
14.3 Key Indicators for Demand
14.4 Key Indicators for Price
15 Competitive Landscape
15.1 Market Structure
15.2 Company Profiles
15.2.1 CSL Behring
15.2.1.1 Company Overview
15.2.1.2 Product Portfolio
15.2.1.3 Demographic Reach and Achievements
15.2.1.4 Certifications
15.2.2 Bayer AG
15.2.2.1 Company Overview
15.2.2.2 Product Portfolio
15.2.2.3 Demographic Reach and Achievements
15.2.2.4 Certifications
15.2.3 Novo Nordisk A/S
15.2.3.1 Company Overview
15.2.3.2 Product Portfolio
15.2.3.3 Demographic Reach and Achievements
15.2.3.4 Certifications
15.2.4 Biogen Inc.
15.2.4.1 Company Overview
15.2.4.2 Product Portfolio
15.2.4.3 Demographic Reach and Achievements
15.2.4.4 Certifications
15.2.5 Sanofi SA
15.2.5.1 Company Overview
15.2.5.2 Product Portfolio
15.2.5.3 Demographic Reach and Achievements
15.2.5.4 Certifications
15.2.6 Octapharma AG
15.2.6.1 Company Overview
15.2.6.2 Product Portfolio
15.2.6.3 Demographic Reach and Achievements
15.2.6.4 Certifications
15.2.7 Others
16 Key Trends and Developments in the Market
List of Figures and Tables
1. Global Bleeding Disorders Therapeutics Market: Key Industry Highlights, 2017 and 2032
2. Global Bleeding Disorders Therapeutics Historical Market: Breakup by Disease Type (USD Million), 2017-2023
3. Global Bleeding Disorders Therapeutics Market Forecast: Breakup by Disease Type (USD Million), 2024-2032
4. Global Bleeding Disorders Therapeutics Historical Market: Breakup by Drug Class (USD Million), 2017-2023
5. Global Bleeding Disorders Therapeutics Market Forecast: Breakup by Drug Class (USD Million), 2024-2032
6. Global Bleeding Disorders Therapeutics Historical Market: Breakup by Region (USD Million), 2017-2023
7. Global Bleeding Disorders Therapeutics Market Forecast: Breakup by Region (USD Million), 2024-2032
8. North America Bleeding Disorders Therapeutics Historical Market: Breakup by Country (USD Million), 2017-2023
9. North America Bleeding Disorders Therapeutics Market Forecast: Breakup by Country (USD Million), 2024-2032
10. Europe Bleeding Disorders Therapeutics Historical Market: Breakup by Country (USD Million), 2017-2023
11. Europe Bleeding Disorders Therapeutics Market Forecast: Breakup by Country (USD Million), 2024-2032
12. Asia Pacific Bleeding Disorders Therapeutics Historical Market: Breakup by Country (USD Million), 2017-2023
13. Asia Pacific Bleeding Disorders Therapeutics Market Forecast: Breakup by Country (USD Million), 2024-2032
14. Latin America Bleeding Disorders Therapeutics Historical Market: Breakup by Country (USD Million), 2017-2023
15. Latin America Bleeding Disorders Therapeutics Market Forecast: Breakup by Country (USD Million), 2024-2032
16. Middle East and Africa Bleeding Disorders Therapeutics Historical Market: Breakup by Country (USD Million), 2017-2023
17. Middle East and Africa Bleeding Disorders Therapeutics Market Forecast: Breakup by Country (USD Million), 2024-2032
18. Global Bleeding Disorders Therapeutics Market Structure
Key Questions Answered in the Report
The global bleeding disorders therapeutics market is projected to grow at a CAGR of 7.4% between 2024 and 2032.
The major drivers of the market include the R&D activities, increasing awareness, favourable reimbursement policies, and low-cost generic drugs.
Growing patient population base and increasing focus on recombinant products by pharmaceutical companies are the key industry trends propelling the market's growth.
What are the major regional markets of bleeding disorders therapeutics, according to the EMR report?
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The different types of diseases are Haemophilia A, Haemophilia B, Von Willebrand disease, and liver disease, among others.
Based on drug class, the market includes plasma derived coagulation factor concentrates and recombinant coagulation factor concentrates, among others.
The major players in the industry are CSL Behring, Bayer AG, Novo Nordisk A/S, Biogen Inc., Sanofi SA, and Octapharma AG, among others.
Analyst Review
The global bleeding disorders therapeutics market was driven by the increasing focus on recombinant products by pharmaceutical companies in the historical period. Aided by the increasing awareness and growing patient population base, the market is expected to witness further growth in the forecast period of 2024-2032, growing at a CAGR of 7.4%.
EMR's meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. The different types of diseases are Haemophilia A, Haemophilia B, Von Willebrand disease, and liver disease, among others. Based on drug class, the market includes plasma derived coagulation factor concentrates and recombinant coagulation factor concentrates, among others. The major regional markets for bleeding disorders therapeutics are North America, Europe, the Asia Pacific, Latin America, the Middle East and Africa. The major players in the industry are CSL Behring, Bayer AG, Novo Nordisk A/S, Biogen Inc., Sanofi SA, and Octapharma AG, among others.
EMR's research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable and help them remain ahead of their competition.
Purchase Options 10% off
Call us
Purchase Full Report
Datasheet
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER